| Literature DB >> 35924775 |
Crystal W Cené, Theresa M Beckie, Mario Sims, Shakira F Suglia, Brooke Aggarwal, Nathalie Moise, Monik C Jiménez, Bamba Gaye, Louise D McCullough.
Abstract
Background Social isolation, the relative absence of or infrequency of contact with different types of social relationships, and loneliness (perceived isolation) are associated with adverse health outcomes. Objective To review observational and intervention research that examines the impact of social isolation and loneliness on cardiovascular and brain health and discuss proposed mechanisms for observed associations. Methods We conducted a systematic scoping review of available research. We searched 4 databases, PubMed, PsycInfo, Cumulative Index of Nursing and Allied Health, and Scopus. Findings Evidence is most consistent for a direct association between social isolation, loneliness, and coronary heart disease and stroke mortality. However, data on the association between social isolation and loneliness with heart failure, dementia, and cognitive impairment are sparse and less robust. Few studies have empirically tested mediating pathways between social isolation, loneliness, and cardiovascular and brain health outcomes using appropriate methods for explanatory analyses. Notably, the effect estimates are small, and there may be unmeasured confounders of the associations. Research in groups that may be at higher risk or more vulnerable to the effects of social isolation is limited. We did not find any intervention studies that sought to reduce the adverse impact of social isolation or loneliness on cardiovascular or brain health outcomes. Conclusions Social isolation and loneliness are common and appear to be independent risk factors for worse cardiovascular and brain health; however, consistency of the associations varies by outcome. There is a need to develop, implement, and test interventions to improve cardiovascular and brain health for individuals who are socially isolated or lonely.Entities:
Keywords: AHA Scientific Statements; brain health; cardiovascular health; loneliness; social isolation
Mesh:
Year: 2022 PMID: 35924775 PMCID: PMC9496293 DOI: 10.1161/JAHA.122.026493
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 6.106
Figure 1Conceptual model examining associations between social isolation, loneliness, and outcomes.
CHD indicates coronary heart disease; and CVD, cardiovascular disease. Adapted from Hodgson et al. Copyright 2020 The Authors. Published on behalf of the Royal Society of Medicine by Sage Publishing. This is an open access article under the terms of the Creative Commons Attribution‐By Author License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited.
Top 5 Suggestions for Future Research
|
Design, implement, and evaluate theory‐driven interventions to mitigate adverse effects of social isolation and loneliness on cardiovascular and brain health. Multicomponent intervention studies would need to include a factorial or other design to allow successful components (eg, active ingredient) to be identified. Design and conduct methodologically rigorous research to examine associations between social isolation, loneliness, and incident CHD, stroke, dementia, and cognitive impairment. Conduct methodologically rigorous research to understand how social isolation and loneliness impact cardiovascular and brain health in populations that are more vulnerable to or at higher risk for social isolation and loneliness, such as children and young adults, underrepresented racial and ethnic groups, sexual minorities, individuals living in rural areas, More research to evaluate the cardiovascular and brain health effects of social isolation and loneliness in times of crisis such as during COVID‐19, More longitudinal research using appropriate methods (eg, path analysis or causal mediation methods) to examine mechanisms by which social isolation and loneliness influence cardiovascular and brain health outcomes. |
CHD indicates coronary heart disease; and COVID‐19, coronavirus disease 2019.
| Writing group member | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
|---|---|---|---|---|---|---|---|---|
| Crystal W. Cené | University of California San Diego Health and University of California San Diego School of Medicine | None | None | None | None | None | None | None |
| Theresa M. Beckie | University of South Florida College of Nursing/College of Medicine | None | None | None | None | None | None | None |
| Brooke Aggarwal | Columbia University, Irving Medical Center | American Heart Association (PI of a research grant) | None | None | None | None | None | None |
| Bamba Gaye | INSERM, Paris Cardiovascular Research Center (France) | None | None | None | None | None | None | None |
| Monik C. Jiménez | Brigham and Women’s Hospital | None | None | None | None | None | None | None |
| Louise D. McCullough | The University of Texas Health Science Center at Houston | American Heart Association | None | None | None | None | None | None |
| Nathalie Moise | Columbia University Medical Center | None | None | None | None | None | None | None |
| Mario Sims | University of Mississippi Medical Center | None | None | None | None | None | None | None |
| Shakira F. Suglia | Emory University Rollins School of Public Health | NIMHD (PI) | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be significant if (1) the person receives $10 000 or more during any 12‐month period, or 5% or more of the person’s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition.
Modest.
Significant.
| Reviewer | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
|---|---|---|---|---|---|---|---|---|
| Nada El Husseini | Duke University Medical Center | None | None | None | None | None | None | None |
| Randi Foraker | Washington University in St. Louis, School of Medicine | None | None | None | None | None | None | None |
| Bernhard Haring | Saarland University Hospital (Germany) | None | None | None | None | None | None | None |
| Deepika Laddu | University of Illinois at Chicago | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be significant if (1) the person receives $10 000 or more during any 12‐month period, or 5% or more of the person’s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition.